IP Library Granted Patent US 10,626,370
Granted Patent B2
US 10,626,370 · App. 15/933,321 · Granted Apr 21, 2020

Process for preparing a cell suspension

Inventors: Dominique Vacher (Mougins, FR); Jean-Noel Gouze (Vallauris, FR)
Assignee: LABORATOIRES GENEVRIER
C12N5/0626B01L7/00C09K5/063C12M23/10C12M41/12C12M45/09C12M45/20B01L9/52B01L2300/1855B01L2300/1877C12N2509/00C12N2523/00Y02E60/145
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,626,370
App. No.
15/933,321
Granted
Apr 21, 2020
Kind
B2
Abstract

Process for carrying out an in vitro biochemical reaction for preparing a cell suspension suitable for application to the skin of a patient.

Claims (18)

1. A process for carrying out an in vitro biochemical reaction for preparing a cell suspension suitable for application to the skin of a patient, the process comprising:

i) activating a warmer, the operation of which is based on an exothermic physical or chemical process,

ii) bringing said warmer into contact with a container containing a solution comprising trypsin by placing the warmer and at least the lower part of the container in a cavity of a support,

iii) placing a skin tissue sample comprising cells suitable for grafting to the skin of the patient in the solution comprising trypsin and incubating at from 30° C. to 40° C. for at least five minutes, and

iv) isolating cells disassociated from the skin sample and suspending the cells in a solution, to thereby provide a cell suspension suitable for application to the skin of a patient.

2. The process as claimed in claim 1 , wherein the contact between the warmer and the container is maintained for at least 10 minutes.

3. The process as claimed in claim 1 , wherein the volume of the solution comprising trypsin is from 3 and to 10 ml, the container containing said solution comprising trypsin is a Petri dish having a diameter of from 7 to 11 cm or a compartment of said dish and wherein the warmer is a disk of which the thickness is from 3 to 7 mm and the diameter is from 7 to 11 cm.

4. The process as claimed in claim 1 , wherein the cavity of the support is circular, with a diameter from 7 to 11.5 cm, and a depth from 5 to 20 mm.

5. The process as claimed in claim 1 , wherein the solution containing trypsin has a concentration of trypsin of from 0.2% to 1%.

6. The process as claimed in claim 1 , wherein the cells isolated in iv) are melanocytes.

7. The process as claimed in claim 1 , wherein the warmer comprises a hermetic plastic pouch containing a sodium acetate-saturated aqueous solution.

8. The process as claimed in claim 7 , wherein the incubating in iii) is at from 30° C. to 37° C. for at least five minutes.

9. The process as claimed in claim 8 , wherein the contact between the warmer and the container is maintained for at least 10 minutes.

10. The process as claimed in claim 8 , wherein the volume of the solution comprising trypsin is from 3 and to 10 ml, the container containing said solution comprising trypsin is a Petri dish having a diameter of from 7 to 11 cm or a compartment of said dish and wherein the warmer is a disk of which the thickness is from 3 to 7 mm and the diameter is from 7 to 11 cm.

11. The process as claimed in claim 8 , wherein the cavity of the support is circular, with a diameter from 7 to 11.5 cm, and a depth from 5 to 20 mm.

12. The process as claimed in claim 8 , wherein the solution containing trypsin has a concentration of trypsin of from 0.2% to 1%.

13. The process as claimed in claim 8 , wherein the cells isolated in (iv) are melanocytes.

14. The process as claimed in claim 8 , wherein the hermetic plastic pouch contains a supercooled sodium acetate-saturated aqueous solution.

Assignments (1)
CHANGE OF NAME Recorded Mar 16, 2022
From: LABOTATORIES GENEVRIER SAS
To: IBSA PHARMA SAS
Reel/Frame 059370/0664 →
Priority Claims (1)
FR 12 55333 · Jun 7, 2012 · national
Continuity (2)
Continuation 14405965
Related Publication 20180298334A1 · Oct 18, 2018
Cited By (4)
US 1,112,812 US 12,270,019 US 12,281,298 US 12,570,949